MedTrace Logo

Greek Study for Endovascular Repair of Ruptured Abdominal Aortic Aneuryms

NCT04471181 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 157

Last updated 2021-08-26

No results posted yet for this study

Summary

This will be a non-randomized, prospective, observational multi-center research study. Its purpose will be to assess the mortality and outcome of EVAR in patients with rAAA. As mentioned in the introduction, EVAR approach for ruptured bdominal aortic aneurysms is nowdays common clinical practice in many vascular centers , and the main treatment option in Hippokrateio General hospital. The same applies in all future participating vascular centers.

Conditions

  • Rupture, Aortic
  • Aneurysm, Abdominal Aortic
  • Aneurysm, Ruptured

Interventions

DEVICE

Endovascular repair of ruptured abdominal aortic aneurysm (EVAR) with Medtronic Endurant

Endovascular repair (EVAR) of ruptured abdominal aortic aneurysms with Medtronic Endurant II, and IIs device

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Aristotle University Of Thessaloniki

    collaborator OTHER

  • Kostantinos Papazoglou

    lead OTHER

Principal Investigators

  • Kostantinos Papazoglou, Professor · Aristotle University Of Thessaloniki

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2022-02-28
Completion
2023-02-28
FDA Device
Yes

Countries

  • Greece

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04471181 on ClinicalTrials.gov